- Home
- SERA vs ECOR Comparison
SERA vs ECOR Comparison
Compare SERA & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SERA | ECOR |
|---|---|---|
| Founded | 2008 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precision Instruments | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 75.2M | 81.0M |
| IPO Year | 2021 | 2018 |
Fundamental Metrics
Financial Performance| Metric | SERA | ECOR |
|---|---|---|
| Price | $2.07 | $9.63 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | 30.8K | ★ 95.0K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.32 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $81,000.00 | ★ $32,032,000.00 |
| Revenue This Year | $554.81 | $33.60 |
| Revenue Next Year | $517.27 | $30.40 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 5.19 | ★ 27.20 |
| 52 Week Low | $1.56 | $4.41 |
| 52 Week High | $3.95 | $10.95 |
Technical Indicators
Market Signals| Indicator | SERA | ECOR |
|---|---|---|
| Relative Strength Index (RSI) | 48.72 | 59.84 |
| Support Level | $1.79 | $5.70 |
| Resistance Level | $2.07 | $10.34 |
| Average True Range (ATR) | 0.11 | 0.85 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 43.57 | 58.07 |
Price Performance
Historical ComparisonAbout SERA Sera Prognostics Inc.
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
About ECOR electroCore Inc.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.